NASHVILLE, Tenn. / Jun 24, 2024 / Business Wire / HCA Healthcare, Inc. (NYSE: HCA) announces the following Webcast:
What: | HCA Healthcare, Inc. 2Q Earnings Release Call |
When: | Tuesday, July 23, 2024 at 9:00 am central (10:00 am eastern) |
How: | Live Audio over the Internet: |
| https://investor.hcahealthcare.com/events-and-presentations/default.aspx | |
Contact:
Frank Morgan, 615-344-2688, Vice President, Investor Relations, This email address is being protected from spambots. You need JavaScript enabled to view it.
If you are unable to listen during the live webcast, the call will be archived on the web site: https://investor.hcahealthcare.com/events-and-presentations/default.aspx.
| Last Trade: | US$311.25 |
| Daily Change: | 3.04 0.99 |
| Daily Volume: | 1,840,548 |
| Market Cap: | US$78.840B |
October 25, 2024 October 17, 2024 July 23, 2024 April 26, 2024 | |
Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MORE
Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...
CLICK TO LEARN MORE
